Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Herman

Showing results (1141-1150 of 1,237) with videos related to

Pageof 124
Sort By:
AJNR. American Journal of Neuroradiology|October 11, 2014
Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study)K R Maravilla, M P Smith, J Vymazal, et al.
JAMA Oncology|July 14, 2022
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical TrialMatthew H G Katz, Qian Shi, Jeff Meyers, et al.
Cancer Biology & Therapy|January 30, 2013
Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cellsNishant Gandhi, Aaron T Wild, Sivarajan T Chettiar, et al.
Anticancer Research|May 31, 2015
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) PatientsGian-Carlo Mattiucci, Massimo Falconi, Ruud G P M VAN Stiphout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2012
Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivorsShinichi Yachida, Catherine M White, Yoshiki Naito, et al.
Advances in Radiation Oncology|June 13, 2020
IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric CancerShalini Moningi, Jaffer A Ajani, Brian D Badgwell, et al.
Annals of Surgery|May 29, 2015
Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical ManagementVicente Valero, Tyler J Saunders, Jin He, et al.
Oncology (Williston Park, N.Y.)|October 18, 2014
ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentationKaryn A Goodman, Sarah A Milgrom, Joseph M Herman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 23, 2014
Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapyAvani S Dholakia, Muhammad Chaudhry, Jeffrey P Leal, et al.
Annals of Surgical Oncology|February 7, 2022
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative ToxicityColin S Hill, Lauren M Rosati, Chen Hu, et al.
Pageof 124

Showing results (1141-1150 of 1,237) with videos related to

Sort By:
Pageof 124
AJNR. American Journal of Neuroradiology|October 11, 2014
Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study)K R Maravilla, M P Smith, J Vymazal, et al.
JAMA Oncology|July 14, 2022
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical TrialMatthew H G Katz, Qian Shi, Jeff Meyers, et al.
Cancer Biology & Therapy|January 30, 2013
Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cellsNishant Gandhi, Aaron T Wild, Sivarajan T Chettiar, et al.
Anticancer Research|May 31, 2015
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) PatientsGian-Carlo Mattiucci, Massimo Falconi, Ruud G P M VAN Stiphout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2012
Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivorsShinichi Yachida, Catherine M White, Yoshiki Naito, et al.
Advances in Radiation Oncology|June 13, 2020
IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric CancerShalini Moningi, Jaffer A Ajani, Brian D Badgwell, et al.
Annals of Surgery|May 29, 2015
Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical ManagementVicente Valero, Tyler J Saunders, Jin He, et al.
Oncology (Williston Park, N.Y.)|October 18, 2014
ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentationKaryn A Goodman, Sarah A Milgrom, Joseph M Herman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 23, 2014
Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapyAvani S Dholakia, Muhammad Chaudhry, Jeffrey P Leal, et al.
Annals of Surgical Oncology|February 7, 2022
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative ToxicityColin S Hill, Lauren M Rosati, Chen Hu, et al.
Pageof 124